rectal cancer

miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma
Edoardo D’Angelo, Carlo Zanon, Francesca Sensi, Maura Digito, Massimo Rugge, Matteo Fassan, Marco Scarpa, Salvatore Pucciarelli, Donato Nitti, Marco Agostini

Journal of Clinical Pathology Apr 2018, 71 (4) 344-350; DOI: 10.1136/jclinpath-2017-204690
Comprehensive lymph node morphometry in rectal cancer using acetone compression
Andreas H Scheel, Rebecca A Reineke, Thilo Sprenger, Suvi Lokka, Julia Kitz, B Michael Ghadimi, Josef Rüschoff, Torsten Liersch, Peter Middel

Journal of Clinical Pathology Jun 2015, 68 (6) 458-464; DOI: 10.1136/jclinpath-2014-202555
Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy
Zhaomin Xu, Mariana E Berho, Adan Z Becerra, Christopher T Aquina, Bradley J Hensley, Reza Arsalanizadeh, Katia Noyes, John R T Monson, Fergal J Fleming

Journal of Clinical Pathology Jul 2017, 70 (7) 584-592; DOI: 10.1136/jclinpath-2016-203995
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Chien-Feng Li, Hong-Lin He, Jaw-Yuan Wang, Hsuan-Ying Huang, Ting-Fe Wu, Chung-Hsi Hsing, Sung-Wei Lee, Hao-Hsien Lee, Jui-Lung Fang, Wen-Tsung Huang, Shang-Hung Chen

Journal of Clinical Pathology Dec 2014, 67 (12) 1056-1061; DOI: 10.1136/jclinpath-2014-202551
Preoperative endoscopic tattooing technique improved lymph node retrieval in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
Yi-Ting Chen, Jaw-Yuan Wang, Jiunn-Wei Wang, Chee-Yin Chai

Journal of Clinical Pathology May 2020, 73 (5) 267-272; DOI: 10.1136/jclinpath-2019-206240
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer
Francesca Pitto, Gabriele Zoppoli, Stefano Scabini, Emanuele Romairone, Roberto Fiocca, Alberto Ballestrero, Marco Sparavigna, Lara Malaspina, Luca Valle, Federica Grillo, Luca Mastracci

Journal of Clinical Pathology Mar 2020, 73 (3) 162-166; DOI: 10.1136/jclinpath-2019-206139
Neoadjuvant chemoradiation and rectal cancer
Runjan Chetty, Aoife J McCarthy

Journal of Clinical Pathology Feb 2019, 72 (2) 97-101; DOI: 10.1136/jclinpath-2018-205592
Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now
Tom P MacGregor, Tim S Maughan, Ricky A Sharma

Journal of Clinical Pathology Oct 2012, 65 (10) 867-871; DOI: 10.1136/jclinpath-2012-200958
Predictive markers of radiotherapy-induced rectal cancer regression
J-S Shin, T-G Tut, V Ho, C S Lee

Journal of Clinical Pathology Oct 2014, 67 (10) 859-864; DOI: 10.1136/jclinpath-2014-202494
Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy
Yi-Ting Chen, Shu-Chuan Tsao, Hung-Pei Tsai, Jaw-Yuan Wang, Chee-Yin Chai

Journal of Clinical Pathology Nov 2016, 69 (11) 974-978; DOI: 10.1136/jclinpath-2016-203638

Main menu

rectal cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

rectal cancer

Pages